SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Jindřich Činátl, Wolfgang E. Berdel et al.|Nature Medicine|2016Cited by 185
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectorsTobias Bexte, Evelyn Ullrich, Anjali Cremer et al.|Molecular Therapy|2024Cited by 44
Inflammatory signaling pathways play a role in SYK inhibitor resistant AMLAnjali Cremer|Scientific Reports|2025Cited by 2
High antileukemic efficiency of CD19-CAR NK cells engineered with Sleeping Beauty transposon vectorsTobias Bexte, Evelyn Ullrich, Anjali Cremer et al.|Klinische Pädiatrie|2022Cited by 0